EXTH-62. TG02, A NOVEL TARGETING OF TRANSCRIPTION AND METABOLISM IN GLIOBLASTOMA

BACKGROUND: Glioblastoma (GBM), a common malignant brain tumor, is highly resistant to most treatments, largely due to disease heterogeneity and resistance mechanisms. We investigated TG02, a multi-kinase inhibitor with established anti-tumor activities in hematologic malignancies, for a potential G...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Su, Yu-Ting, Chen, Robert, Song, Hua, Zhang, Qi, Li, Aiguo, Celiku, Orieta, Meetze, Kristan, Estok, Tom, Maric, Dragan, Zhuang, Zhengping, Yang, Chunzhang, Zhang, Wei, Gilbert, Mark, Wu, Jing
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693086/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.354
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg